Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Kymera Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
KYMR
Nasdaq
8731
https://www.kymeratx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Kymera Therapeutics Inc
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Apr 25th, 2024 2:02 pm
20 Counties with the Highest Cancer Rates in the US
- Apr 25th, 2024 1:20 pm
Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
- Apr 25th, 2024 11:00 am
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
- Apr 8th, 2024 11:00 am
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
- Mar 8th, 2024 3:00 pm
Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)
- Mar 5th, 2024 4:27 am
Analysts' Revenue Estimates For Kymera Therapeutics, Inc. (NASDAQ:KYMR) Are Surging Higher
- Mar 3rd, 2024 12:16 pm
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
- Feb 28th, 2024 12:00 pm
Earnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming Their Forecasts
- Feb 24th, 2024 2:54 pm
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 4:59 pm
Q4 2023 Kymera Therapeutics Inc Earnings Call
- Feb 23rd, 2024 4:24 am
Kymera Therapeutics Inc (KYMR) Reports Q4 and Full Year 2023 Financial Results
- Feb 22nd, 2024 12:35 pm
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
- Feb 22nd, 2024 12:00 pm
Director Jeffrey Albers Sells 5,000 Shares of Kymera Therapeutics Inc (KYMR)
- Feb 22nd, 2024 4:52 am
Repare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
- Feb 20th, 2024 3:00 pm
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?
- Feb 15th, 2024 3:00 pm
Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
- Feb 15th, 2024 12:00 pm
Chief Medical Officer Jared Gollob Sells 46,137 Shares of Kymera Therapeutics Inc
- Feb 10th, 2024 7:56 am
Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
- Jan 31st, 2024 12:00 pm
Director Jeffrey Albers Sells 10,000 Shares of Kymera Therapeutics Inc
- Jan 24th, 2024 5:20 am
Scroll